Bright Minds Biosciences (DRUG) Stock Insights
DRUG$55.23+1.21 +2.24%
$544.79M
Market Cap
-25.14
P/E
—
Forward P/E
—
Score
Bright Minds Biosciences (DRUG) Stock Insights
DRUG price $55.23 +1.21 +2.24%
- Ticker
- DRUG
- Price
- $55.23
- Change
- +1.21 +2.24%
- Market cap ?
- $544.79M
- P/E ?
- -25.14
- Dividend yield ?
- 0.00%
- Beta ?
- 0.09
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the…
Fair value
DRUG fair value Not meaningful. Price $55.23.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-22 | — | -1.15 | — | — |
| 2026-08-17 | -0.17 | -1.39 | — | — |
| 2026-05-20 | -0.80 | -1.06 | — | — |
| 2026-02-12 | -0.70 | -0.98 | — | — |
| 2025-12-23 | -0.41 | -0.56 | — | — |
| 2025-08-14 | -0.53 | -0.59 | — | — |
| 2025-05-15 | -0.29 | -0.39 | — | — |
| 2025-02-13 | 0.01 | -0.23 | — | — |
| 2024-12-30 | -0.12 | -0.44 | — | — |
| 2024-08-14 | 0.04 | — | — | — |
| 2024-05-15 | -0.10 | — | — | — |
| 2024-02-12 | -0.32 | — | — | — |
| 2023-12-29 | -0.30 | — | — | — |
| 2023-08-14 | -0.29 | — | — | — |
| 2023-05-15 | -0.08 | — | — | — |
| 2023-02-07 | -0.10 | — | — | — |
| 2022-12-29 | -0.15 | — | — | — |
| 2022-08-12 | -0.87 | — | — | — |
| 2022-05-16 | -1.52 | — | — | — |
| 2021-12-29 | -1.61 | — | — | — |
| 2021-07-17 | -1.26 | — | — | — |
| 2021-06-17 | -0.46 | — | — | — |
| 2021-03-31 | -0.91 | — | — | — |
| 2020-09-30 | -0.25 | — | — | — |
| 2020-06-30 | -0.03 | — | — | — |
| 2020-03-31 | -0.00 | — | — | — |
| 2019-12-31 | -0.02 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-28 | Cormorant Asset Management, LP | Sell | 109.33K | $89.50 | 9.79M |
| 2024-11-04 | Cormorant Asset Management, LP | Buy | 184.33K | $21.70 | 4.00M |
| 2024-10-16 | Cormorant Asset Management, LP | Buy | 3.11K | $25.22 | 78.36K |
| 2024-10-16 | Cormorant Asset Management, LP | Buy | 7.15K | $24.03 | 171.81K |
| 2024-10-16 | Cormorant Asset Management, LP | Buy | 39.74K | $23.21 | 922.63K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 4.61K | $12.35 | 56.93K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 19.17K | $11.72 | 224.60K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 2.70K | $9.26 | 25.01K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 2.60K | $8.80 | 22.89K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 8.90K | $7.31 | 65.02K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 33.34K | $6.42 | 214.22K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 63.17K | $5.92 | 374.24K |
| 2024-10-15 | Cormorant Asset Management, LP | Buy | 238.10K | $4.53 | 1.08M |
| 2024-10-15 | Cormorant Asset Management, LP | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 102, holders +8 vs prior quarter. Ownership 94.90%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| JUPITER TOPCO LLC | 1.35M | 1.35M | New | 94.82M |
| CORMORANT ASSET MANAGEMENT, LP | 900.00K | -159.33K | -15.04% | 63.18M |
| BLACKROCK, INC. | 686.18K | 64.25K | +10.33% | 48.17M |
| VIVO CAPITAL, LLC | 557.17K | 0 | 0.00% | 39.11M |
| VESTAL POINT CAPITAL, LP | 545.00K | 52.68K | +10.70% | 38.26M |
| BRAIDWELL LP | 483.82K | -55.89K | -10.35% | 33.96M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 433.38K | 862 | +0.20% | 30.42M |
| BALYASNY ASSET MANAGEMENT L.P. | 345.05K | 47.90K | +16.12% | 24.22M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 335.00K | -160.74K | -32.42% | 23.52M |
| POINT72 ASSET MANAGEMENT, L.P. | 327.42K | 327.42K | New | 22.98M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 283.00K | 0 | 0.00% | 19.87M |
| RA CAPITAL MANAGEMENT, L.P. | 265.00K | 0 | 0.00% | 18.60M |
| PARKMAN HEALTHCARE PARTNERS LLC | 205.05K | 164.96K | +411.38% | 14.39M |
| MPM BIOIMPACT LLC | 202.11K | -10.06K | -4.74% | 14.19M |
| WELLINGTON MANAGEMENT GROUP LLP | 171.31K | 34.64K | +25.34% | 12.03M |
| GOLDMAN SACHS GROUP INC | 133.69K | 59.32K | +79.76% | 9.38M |
| EVENTIDE ASSET MANAGEMENT, LLC | 130.01K | 0 | 0.00% | 9.13M |
| STATE STREET CORP | 122.18K | 13.94K | +12.88% | 8.58M |
| SEVEN GRAND MANAGERS, LLC | 120.00K | 0 | 0.00% | 8.42M |
| GREAT POINT PARTNERS LLC | 109.60K | -110.40K | -50.18% | 7.69M |
| GEODE CAPITAL MANAGEMENT, LLC | 104.15K | 15.43K | +17.39% | 7.31M |
| ORBIMED ADVISORS LLC | 93.00K | 53.00K | +132.50% | 6.53M |
| ACUTA CAPITAL PARTNERS, LLC | 92.75K | -19.25K | -17.19% | 6.51M |
| IKARIAN CAPITAL, LLC | 88.95K | -77.70K | -46.62% | 6.24M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 80.06K | 19.58K | +32.37% | 5.62M |
Insights · Dividends · Forecast · Financials · Learn